UBS Group upgraded shares of Elanco Animal Health (NASDAQ:ELAN) from a sell rating to a neutral rating in a research note published on Thursday, 24/7 WallStreet reports. They currently have $30.00 price target on the stock, down from their prior price target of $31.00.
Other analysts have also issued reports about the company. Zacks Investment Research lowered Elanco Animal Health from a buy rating to a hold rating in a research note on Wednesday, July 10th. BMO Capital Markets boosted their price objective on Elanco Animal Health from $32.00 to $35.00 and gave the company a market perform rating in a research note on Friday, May 10th. Finally, Guggenheim began coverage on Elanco Animal Health in a research note on Wednesday, May 22nd. They set a neutral rating on the stock. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus target price of $33.72.
NASDAQ:ELAN opened at $29.36 on Thursday. Elanco Animal Health has a 52-week low of $28.00 and a 52-week high of $37.61. The business’s fifty day moving average is $32.76 and its 200 day moving average is $31.92.
Institutional investors have recently bought and sold shares of the stock. Sterling Investment Advisors Ltd. purchased a new position in Elanco Animal Health during the first quarter worth about $25,000. Water Island Capital LLC purchased a new position in Elanco Animal Health during the first quarter worth about $27,000. FTB Advisors Inc. purchased a new position in Elanco Animal Health during the first quarter worth about $29,000. Steward Partners Investment Advisory LLC purchased a new position in Elanco Animal Health during the second quarter worth about $32,000. Finally, Capital Investment Advisory Services LLC grew its position in Elanco Animal Health by 1,501.4% during the second quarter. Capital Investment Advisory Services LLC now owns 1,121 shares of the company’s stock worth $36,000 after buying an additional 1,051 shares in the last quarter.
About Elanco Animal Health
There is no company description available for Elanco Animal Health Inc
See Also: Google Finance
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.